Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)" | 11 Academia Networks
Direkt zum Inhalt
Publish
Startseite
The Power of Niche Career Hubs
  • Publish
  • Anmelden
  • Create Account
The Power of Niche Career Hubs
LinkedIn
Facebook
BlueSky
Reddit
X
Share Options
Share Options
Whatsapp
Threads
Email
LinkedIn
Facebook
BlueSky
Reddit
X
Whatsapp
Threads
Email

Notice of Change to PAR-23-021, "Avenir Award Program for Genetic or Epigenetic of Substance Use Disorders (DP1 Clinical Trial Optional)"

National Institutes of Health
Typ

Research/project funding

Posted on

15 May 2025

Notice NOT-DA-24-062 from the NIH Guide for Grants and Contracts

More Information

Visit Website

Typ

Research/Project Funding

Posted on

15 May 2025

Turn On Deadline Reminders

, USA

  • not-da-24-062
  • genetic
  • nih guide
  • epigenetic
  • avenir award program
  • scholarship
  • national institutes of health
  • contracts notice

    Also Interesting

    • Research/Project Funding Opportunity

    Notice of Change to PAR-25-139 NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

    • Research/Project Funding Opportunity

    Notice of Change: NINDS Participation in PAR-22-213 "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)"

    • Research/Project Funding Opportunity

    Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Links

Footer menu

  • Our Story
  • Advertise
  • Careers
  • Contact
  • Hilfe
  • Partners
  • Referenzen
  • AGB

Customer Support

+49 (0)30 - 2084712 50
info@11academianetworks.com

Language

Copyright © 2016-2025 11 Academia Networks. All rights reserved

×

Login to your account

E-Mail-Adresse

Passwort

Forgot your password? Click here.

Google
Login with Google
or